Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 24 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E6.36 EPS (ttm)1.11 Insider Own43.29% Shs Outstand71.09M Perf Week6.15%
Market Cap503.53M Forward P/E6.44 EPS next Y1.10 Insider Trans0.00% Shs Float40.33M Perf Month-5.35%
Income79.26M PEG6.36 EPS next Q- Inst Own47.96% Short Float12.69% Perf Quarter-13.24%
Sales157.02M P/S3.21 EPS this Y24.21% Inst Trans8.64% Short Ratio6.05 Perf Half Y34.52%
Book/sh2.32 P/B3.05 EPS next Y-6.78% ROA37.12% Short Interest5.12M Perf Year43.68%
Cash/sh2.02 P/C3.50 EPS next 5Y1.00% ROE48.47% 52W Range3.93 - 10.83 Perf YTD35.72%
Dividend Est.- P/FCF7.84 EPS past 5Y-28.78% ROI47.81% 52W High-34.63% Beta0.92
Dividend TTM0.00 (0.00%) Quick Ratio2.19 Sales past 5Y57.81% Gross Margin87.33% 52W Low80.32% ATR (14)0.41
Dividend Ex-DateMar 25, 2024 Current Ratio3.05 EPS Y/Y TTM144.17% Oper. Margin61.78% RSI (14)44.70 Volatility6.16% 4.89%
Employees45 Debt/Eq0.01 Sales Y/Y TTM44.64% Profit Margin50.48% Recom1.00 Target Price11.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q1230.71% Payout0.00% Rel Volume0.69 Prev Close6.66
Sales Surprise- EPS Surprise- Sales Q/Q205.54% EarningsMay 07 AMC Avg Volume845.49K Price7.08
SMA20-3.32% SMA50-11.91% SMA20018.46% Trades Volume585,660 Change6.31%
Jun-20-24 05:50PM
Jun-17-24 04:05PM
Jun-10-24 07:00AM
May-10-24 09:40AM
May-08-24 09:05AM
06:45AM Loading…
May-07-24 04:05PM
May-03-24 12:00PM
May-02-24 05:45PM
May-01-24 05:00PM
Apr-25-24 05:45PM
Apr-19-24 05:45PM
Apr-15-24 05:50PM
Apr-01-24 04:05PM
Mar-25-24 07:30AM
12:00PM Loading…
Mar-21-24 12:00PM
Mar-13-24 09:24AM
Mar-12-24 05:35PM
Mar-05-24 07:30AM
Feb-21-24 11:17AM
Jan-22-24 07:30AM
Nov-08-23 10:57AM
Nov-07-23 04:05PM
Oct-26-23 07:30AM
Oct-23-23 08:00AM
Oct-04-23 05:31AM
07:30AM Loading…
Sep-06-23 07:30AM
Aug-08-23 04:05PM
Jul-27-23 04:45PM
Jul-18-23 03:59PM
Jul-06-23 05:09PM
Jun-27-23 04:05PM
Jun-06-23 07:30PM
Jun-02-23 08:33AM
May-06-23 08:18AM
May-05-23 05:58AM
May-04-23 04:05PM
Apr-27-23 08:34AM
Apr-19-23 07:49AM
Apr-14-23 07:19AM
Mar-28-23 05:41AM
Mar-16-23 02:13PM
Mar-04-23 07:08AM
Mar-03-23 07:03AM
Mar-02-23 04:05PM
Feb-23-23 10:50AM
Feb-14-23 04:33PM
Feb-08-23 02:35PM
Jan-17-23 07:30AM
Dec-02-22 09:32AM
Nov-05-22 10:24AM
Nov-03-22 04:05PM
Oct-27-22 04:15PM
Oct-13-22 09:57AM
Oct-12-22 04:05PM
Oct-04-22 02:37PM
Sep-30-22 06:15PM
Sep-29-22 08:32AM
Sep-28-22 01:20PM
Sep-26-22 12:08PM
Sep-19-22 06:15PM
Sep-16-22 04:30PM
Sep-15-22 03:00PM
Sep-12-22 06:15PM
Sep-07-22 09:53AM
Sep-02-22 11:19AM
Aug-31-22 04:05PM
Aug-28-22 12:54PM
Aug-26-22 01:15PM
Aug-25-22 12:03PM
Aug-24-22 08:50AM
Aug-23-22 11:27AM
Aug-20-22 11:07AM
Aug-18-22 01:38PM
Aug-17-22 09:29AM
Aug-16-22 04:28PM
Aug-12-22 08:35AM
Aug-10-22 05:29PM
Aug-09-22 07:30AM
Aug-07-22 04:15AM
Aug-05-22 11:11AM
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.